Tuberculosis
Tuberculosis
Tuberculosis
Michael Boyle
Epidemiology
One of the worlds deadliest diseases
1/3 of world infected
Worldwide (2014)
Incidence: 9.6 million
Mortality: 1.5 million
Africans, Native Americans and Eskimos are more susceptible than Caucasians
Most common among the elderly
Etiology
Mycobacterium tuberculosis:
Acid fast, Gram +, obligate
aerobic, non-motile, rod, strict
pathogen
M. tuberculosis bovis,
nonpasteurized milk
Beta-lactamases
LPS
Teichoic acids
Mycolic acids
Pathogenesis
Aerosolized droplets: coughing, sneezing and talking
Inhaled
Deposited in alveoli
Lower segments of the lower and middle lobes
anterior segments of the upper lobes
Cough
Weight loss/anorexia
Fever
Night sweats
Hemoptysis
Chest pain
Fatigue
Differential diagnosis
Acid fast stain: most commonly used in examining sputum for
mycobacterium tuberculosis
It is a method of staining used in bacteriology in which a smear on a slide is
flooded with carbol fuchsin stain, decolorized with acid alcohol, and
counterstained with methylene blue
Acid-fast organisms resist decolorization and appear red against a blue background
under a microscope
This property of being acid-fast is attributable to the presence of lipids and waxes
(mycolic acids) in the cell wall of certain bacteria
Differential diagnosis
PPD skin test: is the classic skin
test for tuberculosis
PPD may indicate an infection but
not whether an infection is active
Purified protein derivative (PPD)
extracted from the mycobacterium
tuberculosis is injected
subcutaneously
The area near the injection is
observed for a delayed
hypersensitivity reaction (necrosis)
A positive test indicates a
hypersensitivity to tuberculoproteins
Differential diagnosis
Well known for its ability to masquerade as other
infectious and disease processes.
The following may resemble pulmonary TB include :
Blastomycosis
Tularemia
Actinomycosis
Mycobacterium avium-intracellulare infection
M chelonae infection
M fortuitum infection
M gordonae infection
M kansasii infection
M marinum infection
M xenopi infection
Squamous cell carcinoma
Treatment
Latent TB
isoniazid (INH)
rifampin (RIF)
rifapentine (RPT)
isoniazid (INH)
rifampin (RIF)
ethambutol (EMB)
pyrazinamide (PZA)
Prognosis
Full resolution is generally expected with few
complications in cases of non-drug resistant TB, when the
drug regimen is completed
Recurrence: 0-14%
Poor prognostic markers: extrapulmonary involvement, an
immunocompromised state, older age, and a history of
previous treatment
Risk factors for dying: reduced baseline TNF- response
to stimulation (with heat-killedM. tuberculosis), low body
mass index, and elevated respiratory rate at TB diagnosis
Summary
Epidemiology: HIV-infected, homeless, malnourished, immigrants
Etiology: M. tuberculosis, acid fast, Gram +, obligate aerobic, non-motile, rod,
strict pathogen
Pathogenesis: Aerosolized droplets, Inhaled
Lungsmacrophageslymph nodes
Miliary TB: disseminated
Mycolic acid
Signs and symptoms: Cough, anorexia, fever, night sweats, hemoptysis, chest
pain, fatigue
Ghon focus, Ghon complex, caseous granuloma
References
Murray, Patrick, Ken Rosenthal, Michael Pfaller. Medical
Microbiology, 7th Edition. W.B. Saunders Company,
2013.
Rubin. Rubin's Pathology: Clinicopathologic Foundations
of Medicine, 6th Edition. Lippincott Williams & Wilkins.
http://www.cdc.gov/tb/